Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

Crawford R, Sully K, Conroy R, Johnson C, Doward L, Bell T, Welch V, Peloquin F, Gater A.

Patient. 2019 Aug 28. doi: 10.1007/s40271-019-00384-9. [Epub ahead of print]

PMID:
31456136
2.

Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients.

Sully K, Trigg A, Bonner N, Moreno-Koehler A, Trennery C, Shah N, Yucel E, Panjabi S, Cocks K.

Eur J Haematol. 2019 Nov;103(5):500-509. doi: 10.1111/ejh.13316. Epub 2019 Sep 5.

PMID:
31444815
3.

Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials.

Arbuckle R, Staunton H, Sully K, Tomkins S, Khindri S, Svedsater H, Nelsen L.

Value Health. 2019 Mar;22(3):340-347. doi: 10.1016/j.jval.2018.09.2845. Epub 2018 Dec 6.

PMID:
30832972
4.

An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments.

Staunton H, Willgoss T, Nelsen L, Burbridge C, Sully K, Rofail D, Arbuckle R.

J Patient Rep Outcomes. 2019 Mar 4;3(1):16. doi: 10.1186/s41687-019-0100-y.

5.

Measuring Health-Related Quality of Life in Tuberous Sclerosis Complex - Psychometric Evaluation of Three Instruments in Individuals With Refractory Epilepsy.

de Vries PJ, Franz DN, Curatolo P, Nabbout R, Neary M, Herbst F, Sully K, Brohan E, Bennett B, Lawson JA.

Front Pharmacol. 2018 Aug 30;9:964. doi: 10.3389/fphar.2018.00964. eCollection 2018.

6.

Generalized Periodic Discharges: A Topical Review.

Sully KE, Husain AM.

J Clin Neurophysiol. 2018 May;35(3):199-207. doi: 10.1097/WNP.0000000000000460. Review.

PMID:
29718829
7.

Altered White-Matter Microstructure in Conduct Disorder Is Specifically Associated with Elevated Callous-Unemotional Traits.

Puzzo I, Seunarine K, Sully K, Darekar A, Clark C, Sonuga-Barke EJS, Fairchild G.

J Abnorm Child Psychol. 2018 Oct;46(7):1451-1466. doi: 10.1007/s10802-017-0375-5.

8.

Reduced Default Mode Connectivity in Adolescents With Conduct Disorder.

Broulidakis MJ, Fairchild G, Sully K, Blumensath T, Darekar A, Sonuga-Barke EJ.

J Am Acad Child Adolesc Psychiatry. 2016 Sep;55(9):800-808.e1. doi: 10.1016/j.jaac.2016.05.021. Epub 2016 Jun 28.

PMID:
27566121
9.

Musculoskeletal Ultrasound Use Among Occupational Medicine Practitioners at the American Occupational Health Conference.

Sully K, Schaefer M, Allen A, Werntz CL 3rd, Ma G, Sayeed Y.

J Occup Environ Med. 2016 Aug;58(8):e315-7. doi: 10.1097/JOM.0000000000000816. No abstract available.

PMID:
27501000
10.

Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.

Lee L, Bounds D, Paterson J, Herledan G, Sully K, Seestaller-Wehr LM, Fieles WE, Tunstead J, McCahon L, Germaschewski FM, Mayes PA, Craigen JL, Rodriguez-Justo M, Yong KL.

Br J Haematol. 2016 Sep;174(6):911-22. doi: 10.1111/bjh.14145. Epub 2016 Jun 17.

PMID:
27313079
11.

Mapping the structural organization of the brain in conduct disorder: replication of findings in two independent samples.

Fairchild G, Toschi N, Sully K, Sonuga-Barke EJ, Hagan CC, Diciotti S, Goodyer IM, Calder AJ, Passamonti L.

J Child Psychol Psychiatry. 2016 Sep;57(9):1018-26. doi: 10.1111/jcpp.12581. Epub 2016 Jun 15.

12.

Investigating the Familial Basis of Heightened Risk-Taking in Adolescents With Conduct Disorder and Their Unaffected Relatives.

Sully K, Sonuga-Barke EJ, Savage J, Fairchild G.

Dev Neuropsychol. 2016 Jan-Mar;41(1-2):93-106. doi: 10.1080/87565641.2016.1145223. Epub 2016 Mar 31.

PMID:
27031280
13.

Constitutive Autophagy and Nucleophagy during Epidermal Differentiation.

Akinduro O, Sully K, Patel A, Robinson DJ, Chikh A, McPhail G, Braun KM, Philpott MP, Harwood CA, Byrne C, O'Shaughnessy RFL, Bergamaschi D.

J Invest Dermatol. 2016 Jul;136(7):1460-1470. doi: 10.1016/j.jid.2016.03.016. Epub 2016 Mar 25.

14.

Feasibility and Implementation of Musculoskeletal Ultrasound Training in Occupational Medicine Residency Education.

Sayeed Y, Marrocco A, Sully K, Werntz C 3rd, Allen A, Minardi J.

J Occup Environ Med. 2015 Dec;57(12):1347-52. doi: 10.1097/JOM.0000000000000567.

PMID:
26641833
15.

Factors That Predict Satisfaction With Medical Care: Data From 27,212 Injured Workers Surveyed for 14 Years.

Joshi AB, McCormick ZL, Sully K, Garvan C, Plastaras CT.

J Occup Environ Med. 2016 Jan;58(1):101-7. doi: 10.1097/JOM.0000000000000578.

PMID:
26565708
16.

The familial basis of facial emotion recognition deficits in adolescents with conduct disorder and their unaffected relatives.

Sully K, Sonuga-Barke EJ, Fairchild G.

Psychol Med. 2015 Jul;45(9):1965-75. doi: 10.1017/S0033291714003080. Epub 2015 Jan 22.

PMID:
25607818
17.

The emerging role of musculoskeletal ultrasound in occupational medicine.

Sayeed Y, Sully K, Allen A, Werntz CL 3rd.

J Occup Environ Med. 2014 Dec;56(12):e160. doi: 10.1097/JOM.0000000000000332. No abstract available.

PMID:
25479308
18.

Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients.

Germaschewski FM, Matheny CJ, Larkin J, Liu F, Thomas LR, Saunders JS, Sully K, Whittall C, Boyle Y, Peters G, Graham NM.

Osteoarthritis Cartilage. 2014 May;22(5):690-7. doi: 10.1016/j.joca.2014.02.930. Epub 2014 Feb 28.

19.

The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling.

Sully K, Akinduro O, Philpott MP, Naeem AS, Harwood CA, Reeve VE, O'Shaughnessy RF, Byrne C.

Oncogene. 2013 Jul 4;32(27):3254-62. doi: 10.1038/onc.2012.338. Epub 2012 Aug 13.

PMID:
22890326
20.

TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrier.

Jackson B, Brown SJ, Avilion AA, O'Shaughnessy RF, Sully K, Akinduro O, Murphy M, Cleary ML, Byrne C.

J Cell Sci. 2011 May 15;124(Pt 10):1681-90. doi: 10.1242/jcs.077552. Epub 2011 Apr 21.

21.

TPL-2-mediated activation of MAPK downstream of TLR4 signaling is coupled to arginine availability.

Mieulet V, Yan L, Choisy C, Sully K, Procter J, Kouroumalis A, Krywawych S, Pende M, Ley SC, Moinard C, Lamb RF.

Sci Signal. 2010 Aug 17;3(135):ra61. doi: 10.1126/scisignal.2000934.

22.

PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR.

Yan L, Mieulet V, Burgess D, Findlay GM, Sully K, Procter J, Goris J, Janssens V, Morrice NA, Lamb RF.

Mol Cell. 2010 Mar 12;37(5):633-42. doi: 10.1016/j.molcel.2010.01.031.

23.

Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.

O'Shaughnessy RF, Welti JC, Sully K, Byrne C.

Development. 2009 Oct;136(20):3423-31. doi: 10.1242/dev.037010. Epub 2009 Sep 17.

24.

Supplemental Content

Support Center